Affiliations 

  • 1 National Drug and Alcohol Research Centre, University of New South Wales, Randwick, Australia
  • 2 Centre for Adolescent Health, Murdoch Children's Research Institute, Melbourne, Australia; Justice Health Unit, Centre for Health Equity; Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia; Health Service and Population Research Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK and Melbourne School of Psychological Sciences, The University of Melbourne, Melbourne, Australia
  • 3 Yale School of Public Health, Division of Epidemiology of Microbial Diseases, Yale University, New Haven, Connecticut, USA; Centre of Excellence on Research in Acquired Immunodeficiency Syndrome (AIDS) (CERIA), University of Malaya, Kuala Lumpur, Malaysia and Department of Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, Connecticut, USA
  • 4 Centre for Adolescent Health, Murdoch Children's Research Institute, Melbourne, Australia; Justice Health Unit, Centre for Health Equity, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia; Griffith Criminology Institute, Griffith University, Gold Coast, Australia; School of Population and Public Health, The University of British Columbia, Vancouver, Canada; Mater Research Institute-UQ, University of Queensland, Brisbane, Australia and School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
  • 5 National Drug and Alcohol Research Centre, University of New South Wales, Randwick, Australia, and Program of International Research and Training (PIRT), University of New South Wales, Randwick, Australia
Int J Prison Health, 2022 Jan 25;18(1):66-82.
PMID: 35401772 DOI: 10.1108/IJPH-02-2021-0018

Abstract

PURPOSE: People in prison are at a higher risk of preventable mortality from infectious disease such as HIV/AIDS, HBV, HCV and TB than those in the community. The extent of infectious disease-related mortality within the prison setting remains unclear. Our aim was to collate available information on infectious disease-related mortality, including the number of deaths and calculate the person-time death rate.

DESIGN/METHODOLOGY/APPROACH: We searched databases between 1 Jan 2000 and 18 Nov 2020 for studies reporting HIV, HBV, HCV, TB and/or HIV/TB-related deaths among people in prison.

FINDINGS: We identified 78 publications drawn from seven UNAIDS regions encompassing 33 countries and reporting on 6,568 deaths in prison over a 20-year period. HIV/AIDS (n=3,305) was associated with the highest number of deaths, followed by TB (n=2,892), HCV (n=189), HIV/TB (n=173), and HBV (n=9). Due to the limitations of the available published data, it was not possible to meta-analyse or in any other way synthesise the available evidence.

ORIGINALITY/VALUE: To our best knowledge, this is the first scoping review focused on deaths due to these infections among people in prison internationally. The gaps identified form recommendations to improve the future collection and reporting of prison mortality data.

RESEARCH IMPLICATIONS: To inform targeted efforts to reduce mortality, there is a need for more, better quality data to understand infectious disease-related mortality in custodial settings. Increased investment in the prevention and management of infectious diseases in custodial settings, and in documenting infectious disease-related deaths in prison, is warranted and will yield public health benefits.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.